Update on the treatment landscape for Renal Cell Carcinoma in Canada
CUA
3/8/22, 7:00 PM
America/New York GMT -4 summer
Description
OBJECTIVES:
- Review new therapies available in RCC
- Examine the impact on sequencing and patient management with new therapies in RCC
- Review patient cases/determine which patient type would benefit from an IO/IO vs. IO/TKI therapy in RCC
Previous registration necessary?
NO
YES
Simultaneous translation ?
NO
YES
Will it be recorded?
NO
YES
Aly-Khan Lalani
Review new therapies available in RCC, Examine the impact on sequencing and patient management with new therapies in RCC, Review patient cases/determine which patient type would benefit from an IO/IO vs. IO/TKI therapy in RCC
Inglês
Speakers
Laurence Albiges
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.